GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Mechanism regulating ErbB signaling network in head and neck cancer

$396,250
Randall H Kramer · University Of California, San Francisco · R01 · FY2016 · DE

Initiation and Evolution of the Ovarian Cancer Microenvironment

$396,245
Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA

Signal Transduction Therapy--Basic Science

$396,183
Elise C. Kohn · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Function of IL35+ B cells in pancreatic cancer

$396,171
Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2024 · CA

Cellular crosstalk in the hematopoietic microenvironment

$396,133
Daniel Lucas · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · HL

Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy

$396,116
Binfeng Lu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

Cancer Biology Research Test-Bed Unit 1: Effects of cell-intrinsic and cell-extrinsic signaling and mechanics on metastasis patterns of pediatric sarcomas

$396,063
James F Amatruda · Ut Southwestern Medical Center · U54 · FY2024 · CA

Project 4 Green-Davis

$396,055
Michael Richard Green · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · CA

Development of IDO PET agents for immunotherapy

$396,007
Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA

Development of IDO PET agents for immunotherapy

$396,007
Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA

Function of the Ras Related Ral Protein

$396,000
Larry Feig · Tufts University Boston · R01 · FY2010 · GM

Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies

$395,960
Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2015 · NS

Theranostic for gastric cancer

$395,933
Valerie Humblet · Collagen Medical, Llc · R44 · FY2023 · CA

Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations

$395,929
Timothy N Phoenix · University Of Cincinnati · R01 · FY2024 · NS

Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte

$395,910
John A. Petros · Cedars-Sinai Medical Center · P01 · FY2010 · CA

Optimizing Targeted Breast Cancer Therapy by Mathematical Modeling and Experimental Studies

$395,906
William Thomas Baumann · Virginia Polytechnic Inst And St Univ · R01 · FY2018 · CA

Transfer of microRNA regulators from glioblastoma to brain microenvironment

$395,879
Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2015 · CA

ADAM17 in pancreatic cancer and pancreatitis

$395,872
Howard C Crawford · State University New York Stony Brook · R01 · FY2011 · CA

Development of murine glioblastoma model for oncolytic HSV therapy

$395,812
Balveen Kaur · Augusta University · R61 · FY2024 · NS

Interleukin-35 and the tumor microenvironment

$395,781
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Investigating and Targeting TAMs in the Glioma Microenvironment

$395,775
Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Targeting tumorigenic pathways in glioblastoma with oncolytic HSV

$395,770
Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2021 · CA

Targeting tumorigenic pathways in glioblastoma with oncolytic HSV

$395,770
Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2020 · CA

Targeting tumorigenic pathways in glioblastoma with oncolytic HSV

$395,770
Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2019 · CA

Project 1: Organismal Evolution

$395,746
Carlo C Maley · Arizona State University-Tempe Campus · U54 · FY2022 · CA